Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Outset Medical
OM
Outset Medical
US Dialysis Pricing Pressure Will Hamper Prospects Despite Emerging Positivity
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
17 Aug 25
Updated
17 Aug 25
1
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$17.00
21.5% undervalued
intrinsic discount
17 Aug
US$13.35
Loading
1Y
50.8%
7D
5.4%
Author's Valuation
US$17.0
21.5% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$17.0
21.5% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-176m
292m
2018
2020
2022
2024
2025
2026
2028
Revenue US$292.5m
Earnings US$36.3m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
11.73%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.39%
Calculation
US$36.33m
Earnings '28
x
23.27x
PE Ratio '28
=
US$845.52m
Market Cap '28
US$845.52m
Market Cap '28
/
39.03m
No. shares '28
=
US$21.66
Share Price '28
US$21.66
Share Price '28
Discounted to 2025 @ 8.42% p.a.
=
US$17.00
Fair Value '25
